HilleVax, Inc. financial data

Symbol
HLVX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
321 Harrison Ave, Suite 500, Boston, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 956 % -49.1%
Debt-to-equity 29.2 % +41%
Return On Equity -62 % -69.8%
Return On Assets -48 % -58.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49.8M shares +26.9%
Common Stock, Shares, Outstanding 49.3M shares +29.5%
Entity Public Float 258M USD +13.3%
Common Stock, Value, Issued 5K USD +25%
Weighted Average Number of Shares Outstanding, Basic 49.2M shares +29.6%
Weighted Average Number of Shares Outstanding, Diluted 49.2M shares +29.6%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 30.3M USD +30.7%
Operating Income (Loss) -167M USD -66.7%
Nonoperating Income (Expense) 10.7M USD +45.4%
Net Income (Loss) Attributable to Parent -156M USD -68.4%
Earnings Per Share, Basic -3.39 USD/shares -171%
Earnings Per Share, Diluted -3.39 USD/shares -171%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 108M USD -31.5%
Marketable Securities, Current 137M USD +59.4%
Assets, Current 253M USD -0.2%
Property, Plant and Equipment, Net 10.4M USD -21.2%
Operating Lease, Right-of-Use Asset 12.4M USD -33.7%
Other Assets, Noncurrent 23K USD 0%
Assets 277M USD -3.35%
Accounts Payable, Current 3.85M USD +2450%
Employee-related Liabilities, Current 474K USD -82.2%
Accrued Liabilities, Current 16M USD -9.32%
Liabilities, Current 49.2M USD +168%
Operating Lease, Liability, Noncurrent 21.9M USD -7.47%
Other Liabilities, Noncurrent 940K USD +1.95%
Liabilities 72M USD +6.26%
Accumulated Other Comprehensive Income (Loss), Net of Tax -937K USD -191%
Retained Earnings (Accumulated Deficit) -476M USD -48.9%
Stockholders' Equity Attributable to Parent 205M USD -6.32%
Liabilities and Equity 277M USD -3.35%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -33M USD -107%
Net Cash Provided by (Used in) Financing Activities 15.1M USD -81.2%
Net Cash Provided by (Used in) Investing Activities -57.7M USD -1832%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 49.8M shares +26.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -75.6M USD -301%
Interest Paid, Excluding Capitalized Interest, Operating Activities 382K USD +99%
Deferred Tax Assets, Valuation Allowance 54.5M USD +102%
Deferred Tax Assets, Gross 58.4M USD +86.2%
Operating Lease, Liability 25.4M USD +5.44%
Depreciation 1.63M USD +300%
Payments to Acquire Property, Plant, and Equipment 153K USD -94.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -157M USD -68.5%
Lessee, Operating Lease, Liability, to be Paid 34.2M USD -9.37%
Property, Plant and Equipment, Gross 12.2M USD -8.17%
Operating Lease, Liability, Current 3.52M USD +705%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.69M USD +2.93%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.79M USD +2.81%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.79M USD -17.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.78M USD +2.6%
Deferred Tax Assets, Operating Loss Carryforwards 10.3M USD +48.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 959K USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.86M USD +2.01%
Operating Lease, Payments 896K USD +2.87%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 3.94M USD -11.6%
Share-based Payment Arrangement, Expense 19M USD +135%
Interest Expense 2.91M USD +106%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%